Concepedia

Vincenzo Damiano

VD

Statistics

Publications

38

Citations

4K

H-Index

31

Active since

1994

Affiliations

University of Naples Federico II(Current)

Federico II University Hospital

University of Pisa

Institut Gustave Roussy

Istituti di Ricovero e Cura a Carattere Scientifico

Vincenzo Damiano is an author at University of Naples Federico II specializing in oncology, medicine, and pharmacology.

Publications per year

1994–2023

38

Publications

38

Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.

Fortunato Ciardiello, Rosa Caputo, Roberto Bianco et al. · PubMed · 2001 · 646 citations

, , +17

Antitumor Activity of ZD6474, a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Human Cancer Cells with Acquired Resistance to Antiepidermal Growth Factor Receptor Therapy

Fortunato Ciardiello, Roberto Bianco, Roberta Caputo et al. · Clinical Cancer Research · 2004 · 347 citations

, , +17

Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225.

Fortunato Ciardiello, Roberto Bianco, Vincenzo Damiano et al. · PubMed · 1999 · 334 citations

, , +15

Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase.

Fortunato Ciardiello, Rosa Caputo, Vincenzo Damiano et al. · PubMed · 2003 · 329 citations

, , +17

Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa).

Cataldo Bianco, Giampaolo Tortora, Roberto Bianco et al. · PubMed · 2002 · 246 citations

, , +15

1–5 of 38